These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11521593)

  • 1. [Evaluation of changes in erythrocyte functions and iron metabolism in patients with chronic renal failure treated by peritoneal dialysis].
    Romanova LA; Lugovskaia SA; Shutov EV; Shmarov DA; Korovina VI; Gorodnicheva VF; Kozinets GI
    Klin Lab Diagn; 2001 Jun; (6):24, 33-6. PubMed ID: 11521593
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anemia in terminal kidney insufficiency: ferrokinetics, erythrocyte survival times and erythrocyte enzymes in chronic dialysis patients].
    Junkers K; Jontofsohn R; Meuret G; Blume KG; Heinze V
    Nucl Med (Stuttg); 1975 Dec; 14(4):355-64. PubMed ID: 1215213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The haemolytic component of the anemia of renal disease (author's transl)].
    Vives Corrons JL
    Sangre (Barc); 1980; 25(5B):676-87. PubMed ID: 6101254
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnosis of iron deficiency in chronic renal failure.
    Fernández-Rodríguez AM; Guindeo-Casasús MC; Molero-Labarta T; Domínguez-Cabrera C; Hortal-Casc n L; Pérez-Borges P; Vega-Díaz N; Saavedra-Santana P; Palop-Cubillo L
    Am J Kidney Dis; 1999 Sep; 34(3):508-13. PubMed ID: 10469862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with zinc protoporphyrin as a marker of endogenous iron availability in chronic haemodialysis patients.
    Baldus M; Salopek S; Möller M; Schliesser J; Klooker P; Reddig J; Gansert U; Brass H
    Nephrol Dial Transplant; 1996 Mar; 11(3):486-91. PubMed ID: 8710158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron in the treatment of anemia in dialysis patients: an important support to erythropoietin.
    Gallieni M
    Int J Artif Organs; 1998 Nov; 21(11):681-6. PubMed ID: 9894741
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of magnesium and zinc levels in blood in end stage renal disease patients treated by hemodialysis or peritoneal dialysis.
    Pietrzak I; Bladek K; Bulikowski W
    Magnes Res; 2002 Dec; 15(3-4):229-36. PubMed ID: 12635877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of using human recombinant erythropoietin in a patient treated by peritoneal dialysis complicated by chronic infection of the tunnel of the dialysis catheter].
    Wanic-Kossowska M; Grzegorzewska A; Piszczek I; Krzymański M
    Pol Tyg Lek; 1992 Aug 7-17; 47(31-33):694-5. PubMed ID: 1492040
    [No Abstract]   [Full Text] [Related]  

  • 9. Human recombinant erythropoietin (rHuEPO) in the treatment of anemia in patients with chronic renal failure (CRF): experience with a group of patients on chronic haemodialysis treatment.
    Ramírez B; Flores A; Pérez F; Córdoba C; García L; Vázquez G
    Transplant Proc; 1991 Apr; 23(2):1833-4. PubMed ID: 2053170
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of subcutaneous low-dose erythropoietin in patients with chronic renal failure despite functional iron deficiency.
    Bedani PL; Cecchetti E; Gilli P
    Nephron; 1995; 71(4):459-60. PubMed ID: 8587628
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversing the anemia of renal failure.
    Hatch FE
    Hosp Pract (Off Ed); 1990 Feb; 25(2A):25-34. PubMed ID: 2105980
    [No Abstract]   [Full Text] [Related]  

  • 12. Iron management in end-stage renal disease.
    Fishbane S; Maesaka JK
    Am J Kidney Dis; 1997 Mar; 29(3):319-33. PubMed ID: 9041207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Etiopathogenic mechanisms of anemia in hemodialysis patients].
    Marco Franco JE; Alarcón Zurita A; Dalmau Diana M; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Ribas Mundó M
    Rev Clin Esp; 1983 Jan; 168(2):83-5. PubMed ID: 6344155
    [No Abstract]   [Full Text] [Related]  

  • 14. Iron kinetics in healthy individuals and in chronic renal insufficiency.
    Eschbach JW
    Contrib Nephrol; 1984; 38():129-34. PubMed ID: 6713890
    [No Abstract]   [Full Text] [Related]  

  • 15. The management of iron metabolism in recombinant human erythropoietin treated dialysis patients by Dutch nephrologists.
    Kooistra MP; Marx JJ
    Nephrol Dial Transplant; 1997 May; 12(5):879-83. PubMed ID: 9175038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron replacement in rHuEPO-treated dialysis patients: DOQI and beyond.
    Mittman N
    Am J Kidney Dis; 1999 Jul; 34(1):173-6. PubMed ID: 10401035
    [No Abstract]   [Full Text] [Related]  

  • 17. Anemia of renal failure. A review.
    Diaz-Buxo JA; Frohnert PP
    Minn Med; 1974 May; 57(5):374-8. PubMed ID: 4824718
    [No Abstract]   [Full Text] [Related]  

  • 18. Is anaemia during continuous ambulatory peritoneal dialysis really better than during haemodialysis?
    Salahudeen AK; Keavey PM; Hawkins T; Wilkinson R
    Lancet; 1983 Nov; 2(8358):1046-9. PubMed ID: 6138598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heme synthesis in chronic renal failure: the effects of hemodialysis, peritoneal dialysis and erythropoietin treatment.
    Siersema PD; de Rooij FW; Edixhoven-Bosdijk A; Weimar W; Wilson JH
    Nephron; 1995; 71(3):297-302. PubMed ID: 8569978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematologic complications of chronic renal failure.
    Fried W
    Med Clin North Am; 1978 Nov; 62(6):1363-79. PubMed ID: 368451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.